Search Results - "Kremenevskaja, N"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Wnt-5a has tumor suppressor activity in thyroid carcinoma by KREMENEVSKAJA, N, VON WASIELEWSKI, R, RAO, A. S, SCHÖFL, C, ANDERSSON, T, BRABANT, G

    Published in Oncogene (24-03-2005)
    “…Stabilization of beta-catenin by inhibition of its phosphorylation is characteristic of an activation of the canonical Wnt/beta-catenin signaling pathway and…”
    Get full text
    Journal Article
  2. 2

    Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up by Olsson, D S, Buchfelder, M, Wiendieck, K, Kremenevskaja, N, Bengtsson, B-Å, Jakobsson, K-E, Jarfelt, M, Johannsson, G, Nilsson, A G

    Published in European journal of endocrinology (01-06-2012)
    “…ObjectiveMost patients who have been treated for craniopharyngioma (CP) are GH deficient (GHD). GH replacement therapy (GHRT) may stimulate tumour regrowth;…”
    Get full text
    Journal Article
  3. 3

    Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/β-catenin signalling by Rao, A S, Kremenevskaja, N, Resch, J, Brabant, G

    Published in European journal of endocrinology (01-12-2005)
    “…Background: Lithium, clinically used in the treatment of bipolar disorders, is well known to induce thyroid growth. However, the mechanism involved is only…”
    Get full text
    Journal Article
  4. 4

    Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up by Olsson, D S, Buchfelder, M, Wiendieck, K, Kremenevskaja, N, Bengtsson, B-Å, Jakobsson, K-E, Jarfelt, M, Johannsson, G, Nilsson, A G

    Published in European journal of endocrinology (01-07-2012)
    “…The journal apologizes for an error in Fig. 2 of this article published in the European Journal of Endocrinology 166 1061–1068. The GH-treated group and…”
    Get full text
    Journal Article
  5. 5

    Wnt/β-Catenin Signaling Mediates Antineoplastic Effects of Imatinib Mesylate (Gleevec) in Anaplastic Thyroid Cancer by Rao, Annavarapu Srinivas, Kremenevskaja, Natalia, von Wasielewski, Reinhard, Jakubcakova, Vladimira, Kant, Shashi, Resch, Julia, Brabant, Georg

    “…Context: Dysregulation of Wnt signaling is a key step in neoplastic thyrocyte proliferation. However, it is unclear whether the selective tyrosine kinase (TK)…”
    Get full text
    Journal Article